Dementia After Stroke
Stroke 35:1264-1269, Ivan,C.S.,et al, 2004
Stenting of Symptomatic M1 Stenosis of Middle Cerebral Artery
Stroke 35:1375-1380, Jiang,W.-J.,et al, 2004
Direct Thrombin Inhibition
Stroke 35:1519-1522, Elkind,M.S.V. &Sacco,R.L., 2004
Aspriin and Clopidogrel Compared with Colpidogrel Alone After Recent Ischaemic Stroke or Transient Ischaemic Attack in High-Risk Patients (MATCH): Randomised, Double-Blind, Placebo-Controlled Trial
Lancet 364:331-337, Diener,H.-C.,et al, 2004
Flavivirus Encephalitis
NEJM 351:370-378, Solomon,T., 2004
Late "Spectacular Shrinking Deficit"?
Arch Neurol 61:129-130, de Assis Aquino Godim,F. &Thomas,F.P., 2004
The Effect of Spinal Cord Stimulation in Patients with Chronic Reflex Sympathetic Dystrophy: Two Years' Follow-up of the Randomized Controlled Trial
Ann Neurol 55:13-18,5, Kemler,M.A.,et al, 2004
The Redefinition of TIA, The Uses and Limitations of DWI in Acute Ischemic Cerebrovascular Syndromes
Neurol 62:359-360, Warach,S.&Kidwell,C.S., 2004
Magnesium for Acute Stroke (Intravenous Magnesium Efficacy in Stroke Trial):Randomised Controlled Trial
Lancet 363:439-445,414, Goldstein,L.B., 2004
Tissue Distribution of Bovine Spongiform Encephalopathy Agent in Primates after Intravenous or Oral Infection
Lancet 363:422-428,411, Herzog,C.,et al, 2004
Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion
Lancet 363:417-421,411, Llewelyn,C.A.,et al, 2004
DWI Abnormalities and Clinical Characteristics in TIA Patients
Neurol 62:376-380,359, Inatomi,Y.,et al, 2004
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004
Reversible Leukoencephalopathy Associated with Cerebral Amyloid Angiopathy
Neurol 62:494-497, Oh,U.,et al, 2004
Migraine
Lancet 363:381-391, Silberstein,S.D., 2004
Bovine Spongiform Encephalopathy in the United States - An Epidemiologist's View
NEJM 350:539-542, Donnelly,C.A., 2004
Lowering Homocysteine in Patients with Ischemic Stroke to Prevent Recurrent Stroke, Myocardial Infarction, and Death
JAMA 291:565-575,621, Toole,J.F.,et al, 2004
The New Antiepileptic Drugs, Scientific Review
JAMA 291:605-614, LaRoche,S.M.&Helmers,S.L., 2004
The New Antiepileptic Drugs, Clinical Applications
JAMA 291:615-620, LaRoche,S.M.&Helmers,S.L., 2004
Epilepsy
JAMA 291:654, Parmet,S, 2004
Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function
Arch Neurol 61:661-666, Arvanitakis,Z.,et al, 2004
Therapy for Nerve Agent Poisoning
Arch Neurol 61:649-652, Newmark,J., 2004
Meningiomas
Lancet 363:1535-1543, Whittle,I.R.,et al, 2004
Ropinirole in Gilles de la Tourette Syndrome
Neurol 62:1626-1627, Anea,M.H.,et al, 2004
Percutaneous Closure of Patent Foramen Ovale Reduces the Frequency of Migraine attacks
Neurol 62:1399-1401, Schwerzmann,M.,et al, 2004
Efficacy and Tolerability for the New Antiepileptic Drugs I: Treatment of New Onset Epilepsy
Neurol 62:1252-1260, French,J.A.,et al, 2004
Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy
Neurol 62:1261-1273, French,J.A.,et al, 2004
Efficacy of Pergolide in Treatment of Restless Legs Syndrome
Neurol 62:1391-1397, Trenkwalder,C.,et al, 2004
Paraneoplastic "Stiff Person Syndrome" with Metastatic Adenocarcinoma and anti-Ri Antibodies
Neurol 62:1402-1404, McCabe,D.J.H.,et al, 2004
Nimodipine for Treatment of Primary Thunderclap Headache
Neurol 62:1414-1416, Lu,S.-R.,et al, 2004
Brainstem Involvement in Hypertensive Encephalopathy
Neurol 62:1417-1419, Cruz-Flores,S.,et al, 2004
Plasmapheresis Improves Outcome in Postinfectious Cerebellitis Induced by Epsteiin-Barr Virus
Neurol 62:1443, Schmahmann,J.D., 2004
Treatment of Refractory Neurosarcoidosis with Cladribine
NEJM 350:1798-1799, Tikoo,R.K.,et al, 2004
Fibromuscular Dysplasia
NEJM 350:1862-1871, Slovut,D.P. &Olin,J.W., 2004
Transient Ischemic Attack and Stroke Can Be Differentiated by Analyzing Early Diffusion-Weighted imaging Signal Intensity Changes
Stroke 35:1095-1099, Winbeck,K.,et al, 2004
Favorable Outcome of Ischemic Stroke in Patients Pretreated with Statins
Stroke 35:1117-1123, Marti-Fabregas,J.,et al, 2004
Antiplatelet Therapy for Preventing Stroke and Other Vascular Events After Carotid Endarterectomy
Stroke 35:1227-1228, Engelter,S. &Lyrer,P., 2004
A Double-blind Placebo-controlled Trial of Botulinum Toxin B for Sialorrhea in Parkinson's Disease
Neurol 62:37-40, Ondo,W.G.,et al, 2004
Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke
Stroke 35:147-150, Brown,D.L.,et al, 2004
Steroids Have No Role in Stroke Therapy
Stroke 35:229-231, Poungvarin,N.,et al, 2004
Steroids May Have a Role in Stroke Therapy
Stroke 35:228-229,230, Norris,J.W., 2004
Transmissible Spongiform Encephalopathies
Lancet 363:51-61, Collins,S.J.,et al, 2004
Neuroprotection in Parkinson Disease, Mysteries, Myths, and Misconceptions
JAMA 291:358-364, Schapira,A.H.V.&Olanow,C.W., 2004
Recipients of Blood or Blood Products "at vCJD risk"
BMJ 328:118-119, Bird,S.M., 2004
Brain Metastases
The Neurologist 10:31-46, Klos,K.J.&O'Neill,B.P., 2004
Imaging Cerebral Atrophy:Normal Ageing to Alzheimer's Disease
Lancet 363:392-394, Fox,N.C.&Schott,J.M., 2004
Hemicraniectomy for Massive Middle Cerebral Artery Territory Infarction,A Systematic Review
Stroke 35:539-543, Gupta,R.,et al, 2004
Prion Deposition in Olfactory Biopsy of Sporadic Creutzfeldt-Jakob Disease
Ann Neurol 55:294-296, Tabaton,M.,et al, 2004
Clinical and MRI Outcome after Autologous Hematoipoietic Stem Cell Transplantation in MS
Neurol 62:282-284,168, Saiz,A.,et al, 2004
Reversible Abnormalities of DWI in High-Altitude Cerebral Edema
Neurol 62:335-336, Wong,S.H.,et al, 2004